Abstract

In emerging countries like India, still, the diagnosis of diabetes mellitus is done on the bases of patient's age due to financial problems, unavailability of instruments, techniques and high cost of diagnostic tests which is not affordable by poor and normal people. Some modem tests include the GAD Antibodies test and the C-peptide test which are used in the diagnosis of type I and type 2 diabetes mellitus. This article shows the findings and Imaging techniques that can be done to identify the type of diabetes mellitus based on the size, echotexture, volume and weight of the pancreas. This imaging is cost-effective and can be afforded by all types of people.

Keywords: Imagining Study; Diabetes Diagnosis; Type I Diabetes; Type 2 Diabetes; Pancreas Size

References

1. American Diabetes Association. "Standards of medical care in diabetes—2016: summary of revisions”. Diabetes Care 39.1 (2016): S4-S5.
2. Cnop Miriam., et al. "Progressive loss of β-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes”. Diabetes Care 30.3 (2007): 677-682.
3. Brozzi Flora., et al. "Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms”. Diabetologia 58.10 (2015): 2307-2316.
4. Butler Alexandra E., et al. "Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid”. Diabetes 52.9 (2003): 2304-2314.
5. Donath MY and Philippe A Halban. "Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications”. Diabetologia 47.3 (2004): 581-589.
6. Löhr M and G Klöppel. "Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy”. Diabetologia 30.10 (1987): 757-762.
7. Rahier Jacques., et al. "Pancreatic β‐cell mass in European subjects with type 2 diabetes”. Diabetes, Obesity and Metabolism 10 (2008): 32-42.
8. Nakanishi Koji., et al. "Relationships among residual β cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus”. Metabolism 42.2 (1993): 196-203.
9. Meier JJ., et al. "Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?” Diabetologia 48.11 (2005): 2221-2228.
10. Stamm BH. "Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: A systematic study of 112 autopsies in patients without known pancreatic disease”. Human Pathology 15.7 (1984): 677-683.
11. Putzke HP and G Friedrich. "Pancreatopathy in diabetes mellitus”. Zentralblatt fur Allgemeine Pathologie u. pathologische Anatomie 131.1 (1986): 37-41.
12. Campbell-Thompson Martha., et al. "Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes”. Journal of the American Medical Association 308.22 (2012): 2337-2339.
13. Campbell-Thompson Martha L., et al. "The influence of type 1 diabetes on pancreatic weight”. Diabetologia 59.1 (2016): 217-221.
14. Szczepaniak Lidia S., et al. "Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population”. American Journal of Physiology-Endocrinology and Metabolism 288.2 (2005): E462-E468.
15. Rosqvist Fredrik., et al. "Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans”. Diabetes 63.7 (2014): 2356-2368.
16. Kim So Yeon., et al. "Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications”. Radiology 271.1 (2014): 104-112.
17. Tushuizen, Maarten E., et al. "Pancreatic fat content and β-cell function in men with and without type 2 diabetes”. Diabetes Care 30.11 (2007): 2916-2921.
18. Heni Martin, et al. "Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study”. Diabetes/Metabolism Research and Reviews 26.3 (2010): 200-205.
19. Alzaid A., et al. "The size of the pancreas in diabetes mellitus”. Diabetic Medicine 10.8 (1993): 759-763.
20. Lim Soo., et al. "Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes”. Acta Diabetologica 51.5 (2014): 739-748.
21. Macauley Mavin., et al. "Altered volume, morphology and composition of the pancreas in type 2 diabetes”. PloS One 10.5 (2015): e0126825.
22. Silva Maria ER, et al. "Ultrasonographic abnormalities of the pancreas in IDDM and NIDDM patients”. Diabetes Care 16.9 (1993): 1296-1297.
23. Goda K., et al. "Pancreatic volume in type 1 und type 2 diabetes mellitus”. Acta Diabetologica 38.3 (2001): 145-149.
24. Garcia Tiago Severo., et al. "Pancreatic size and fat content in diabetes: a systematic review and meta-analysis of imaging studies”. PloS one 12.7 (2017): e0180911.
25. Fonseca V., et al. "Size of pancreas in diabetes mellitus: a study based on ultrasound”. British Medical Journal (Clinical Research Edition) 291.6504 (1985): 1240-1241.
26. Regnell Simon Eringsmark., et al. "Pancreas volume and fat fraction in children with type 1 diabetes”. Diabetic Medicine 33.10 (2016): 1374-1379.
27. Kreel Louis., et al. "Computed tomography of the normal pancreas”. Journal of Computer Assisted Tomography 1.3 (1977): 290-299.
28. Laakso M and Pyörälä K. “Age of onset and type of diabetes”. Diabetes Care 8.2 (1985): 114-117.
29. Otani T., et al. “Age of onset and type of Japanese younger diabetics in Tokyo”. Diabetes Research and Clinical Practice 10.3 (1990): 241-244.